Ember Therapeutics, Inc. (EMBT)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2014 | 2013 | 2012 |
|---|---|---|---|
| Operating Cash Flow | -16.72 Thousand | -22.59 Thousand | -4807.00 |
| Net Income | -23.24 Thousand | -16.33 Thousand | -12.78 Thousand |
| Depreciation & Amortization | - | - | - |
| Deferred income taxes | - | - | - |
| Stock-based compensation | - | - | - |
| Change in working capital | 6521.00 | -6257.00 | 7980.00 |
| Other non-cash items | - | - | - |
| Investing Cash Flow | - | - | - |
| Investments in PPE | - | - | - |
| Acquisitions | - | - | - |
| Investment purchases | - | - | - |
| Sales/Maturities of investments | - | - | - |
| Other Investing Activities | - | - | - |
| Financing Cash Flow | 15.65 Thousand | 21.5 Thousand | - |
| Debt repayment | - | - | - |
| Dividends payments | - | - | - |
| Common Stock Repurchased | - | - | - |
| Common Stock Issuance | - | - | - |
| Other Financing Activities | - | - | - |
| Accounts receivables | - | - | - |
| Accounts payables | 700.00 | -11.51 Thousand | 3063.00 |
| Inventory | - | - | - |
| Other working capital | 5821.00 | 5256.00 | 4917.00 |
| Cash at beginning of period | 1255.00 | 2344.00 | 7151.00 |
| Cash at end of period | 184.00 | 1255.00 | 2344.00 |
| Capital Expenditure | - | - | - |
| Effect of forex changes on cash | - | - | - |
| Net cash flow / Change in cash | -1071.00 | -1089.00 | -4807.00 |
| Free Cash Flow | -16.72 Thousand | -22.59 Thousand | -4807.00 |
| Breakdown | 2015 Q3 | 2015 Q2 | 2015 Q1 | 2014 Q4 | 2014 FY | 2014 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1351.00 | -7400.00 | -5280.00 | -6064.00 | -23.24 Thousand | -5418.00 |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -4672.00 | 5881.00 | 940.00 | 2916.00 | 6521.00 | 2845.00 |
| Other non-cash items | - | - | - | - | - | - |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 5500.00 | 2000.00 | 6500.00 | 1150.00 | 15.65 Thousand | 3500.00 |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -6275.00 | 4325.00 | -550.00 | 1400.00 | 700.00 | 1350.00 |
| Inventory | - | - | - | - | - | - |
| Other working capital | 1603.00 | 1556.00 | 1490.00 | 1516.00 | 5821.00 | 1495.00 |
| Cash at beginning of period | 2825.00 | 2344.00 | 184.00 | 2182.00 | 1255.00 | 1255.00 |
| Cash at end of period | 2302.00 | 2825.00 | 2344.00 | 184.00 | 184.00 | 2182.00 |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -523.00 | 481.00 | 2160.00 | -1998.00 | -1071.00 | 927.00 |
| Free Cash Flow | -6023.00 | -1519.00 | -4340.00 | -3148.00 | -16.72 Thousand | -2573.00 |
FIP
HLOC
SANDHAR
LILAB
3666
GNRV